Evidence map›Paper›PMID 27443845›Full record

ArticleMolecular and cellular biochemistry2016

Cardioprotective effects of rutin via alteration in TNF-α, CRP, and BNP levels coupled with antioxidant effect in STZ-induced diabetic rats.

Ravi Saklani, Suresh Kumar Gupta, Ipseeta Ray Mohanty, Binit Kumar, Sushma Srivastava, Rajani Mathur

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular and cellular biochemistry, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed, 1 pooled it
5.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 1 synthesis or guideline pooled it, 75 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Therapeutic Power of Date Fruit (Food science & nutrition · 2025
    Review
  6. Review
  7. Review
  8. Rutin: a pain-relieving flavonoid.Inflammopharmacology · 2025
    Review
  9. Review
  10. The immunology of diabetic cardiomyopathy.Frontiers in endocrinology · 2025
    Review
  11. Review
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Review
  19. Safety and tolerability of Pau d' Arco (Advances in integrative medicine · 2022
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 2 countries.

Ravi SaklaniDelhi Institute of Pharmaceutical Sciences and Research (DIPSAR), University of Delhi, Pushp Vihar Sec-3, New Delhi, 110017, India.
Suresh Kumar GuptaDelhi Institute of Pharmaceutical Sciences and Research (DIPSAR), University of Delhi, Pushp Vihar Sec-3, New Delhi, 110017, India. skgup@hotmail.com.
Ipseeta Ray MohantyMahatma Gandhi Memorial Medical College, Indore, India.
Binit KumarTufts University, Boston, USA.
Sushma SrivastavaDelhi Institute of Pharmaceutical Sciences and Research (DIPSAR), University of Delhi, Pushp Vihar Sec-3, New Delhi, 110017, India.
Rajani MathurDelhi Institute of Pharmaceutical Sciences and Research (DIPSAR), University of Delhi, Pushp Vihar Sec-3, New Delhi, 110017, India.
Delhi Pharmaceutical Science and Research University · INUniversity of Delhi · INMahatma Gandhi Memorial Medical College · INTufts University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Diabetic cardiomyopathy (DCM) is a dreadful complication of diabetes responsible for 80 % mortality in diabetic patients, but unfortunately its pharmacotherapy is still incomplete. Rutin is a naturally occurring flavonoid having a long history of use in nutritional supplements for its action against oxidative stress, inflammation, and hyperglycemia, the key players involved in the progression of DCM, but remains unexplored for its role in DCM. This study was conducted to address this lacuna. It was performed in 4-week-old Streptozotocin-induced (45 mg/kg) diabetic rats for a period of 24 weeks to mimic the cardiotoxic effect of chronic hyperglycemia in diabetic patient's heart and to investigate the effect of rutin (50 mg/kg/day) in ameliorating these effects. Heart of the diabetic rats showed altered ECG parameters, reduced total antioxidant capacity, increased inflammatory assault, and degenerative changes. Interestingly, rutin treatment significantly ameliorated these changes with decrease in blood glucose level (p > 0.001), % HbA1c (p > 0.001) and reduced expression of TNF-α (p < 0.001), CRP (p < 0.001), and BNP (p < 0.01) compared to diabetic control rats. In addition, rutin provided significant protection against diabetes associated oxidative stress (p < 0.05), prevented degenerative changes in heart, and improved ECG parameters compared to diabetic control rats. The heart-to-body weight ratio was significantly reduced in rutin treatment group compared to diabetic control rats (p < 0.001). In conclusion, this study implicates that oxidative stress and inflammation are the central players involved in the progression of DCM and rutin ameliorates DCM through its antioxidant and anti-inflammatory actions on heart.

Indexed as

Diabetes Mellitus, ExperimentalDiabetic CardiomyopathiesAnimalsAntioxidantsCardiotonic AgentsC-Reactive ProteinFemaleNatriuretic Peptide, BrainOxidative StressRatsRats, WistarRutinTumor Necrosis Factor-alphaAntioxidantsCardiotonic AgentsC-Reactive ProteinNatriuretic Peptide, BrainRutinTumor Necrosis Factor-alphaDiabetesDiabetic cardiomyopathyDiabetic complicationsRutin

Identifiers

PMID27443845
OpenAlexW2505369960

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.